Researchers published the study covered in this summary on researchsquare.com as a preprint that has not yet been peer reviewed.
Key Takeaways
In patients with type 2 diabetes who underwent bariatric surgery, higher serum magnesium levels at baseline and 1-year following bariatric surgery were associated with better glycemic control and a greater likelihood of diabetes remission during the year after bariatric surgery.
Why This Matters
After bariatric surgery, micronutrient deficiencies are one of the most common and compelling problems, and supplementation is recommended.
Abnormally low levels of serum magnesium are relatively common among patients with diabetes, especially those with inadequately controlled glycemia.
Prior reports have documented that low dietary magnesium intake is associated with an increased risk of developing type 2 diabetes and diminished glycemic control in those with type 2 diabetes.
Bariatric surgery remains the most effective treatment for severe obesity and can lead to improvement or even resolution of type 2 diabetes.
No known previous study has assessed the relationship between magnesium supplementation, magnesium serum levels, and glycemic control in patients with type 2 diabetes both before and after bariatric surgery, nor the relationships between these measures and diabetes remission rates.
Study Design
This was a retrospective, observational study of 403 patients (79% women) with obesity (body mass index ≥ 40 kg/m
